The ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/adom.202202122.ally inaccessible in existing endogenous and exogenous fluorophores in body. As a consequence, UCNPs hold promise as imaging agents for a myriad of biomedical applications, such as high contrast in vivo imaging and high-sensitivity biosensing. [3] Moreover, UCNPs can incorporate different functional lanthanide ions to impart new functional imaging modalities, such as trivalent gadolinium (Gd 3+ ) for magnetic resonance imaging (MRI) and ytterbium (Yb 3+ ) for X-ray computed tomography (CT), making them attractive for multimodal imaging. [4] Despite recent success of UCNPs on molecular imaging, the lack of therapeutic abilities precludes their uses as therapeutic agents for cancer treatment. Nowadays, combining complementary diagnostic and therapeutic abilities into one single nanoplatform, that is, "theranostic" agent, is on demand, in which the diagnostic role reports the presence of a disease, its status and its response to a specific treatment, while the therapeutic role implements imagingguided surgery, radiation therapy, light therapy, immunotherapy or chemotherapy to treat lesions, bringing about revolutionary advances in medicine and healthcare. Combining therapeutic agents and molecular imaging contrast agents to form heterostructures constitutes an essential means in developing theranostic agents, as it is of extreme difficulty to simultaneously achieve both diagnosis and therapy roles using single imaging or therapeutic alone.Metal-organic frameworks (MOFs) are distinguished exceptional for a set of forefront applications, including catalysis, security, environmental uses, and, especially, biotherapy. MOFs are highly crystallized porous materials formed by self-assembly of metal ions/metal clusters as nodes and organic ligands as link units, [5] which possess innate structural advantages of open pore structure, high porosity, and easily modified and functionalized surface, facilitating the confinement of chemotherapy drugs in the pores for diffusion-controlled drug delivery. [6] Moreover, certain photosensitizers such as tetrakis(4-carboxyphenyl)porphyrin (TCPP) can be used as the framing organic ligands, rendering MOF itself (e.g., as effective therapeutic drug, avoiding self-quenching of molecular photosensitizer, and thus producing higher amount of singlet oxygen ( 1 O 2 )